Yes, low vitamin B12 can cause tinnitus, and the link is biologically direct rather than coincidental. B12 is required to build and maintain myelin, the fatty insulation wrapped around the cochlear nerve and the auditory pathways of the brainstem. When serum B12 falls below roughly 200 pg/mL, myelin repair slows, nerve conduction becomes erratic, and the auditory system can generate the phantom sound we call tinnitus. The association is strongest in people over 60, in strict vegans, and in anyone taking metformin or acid-suppressing drugs long term. It is a treatable contributor, not an automatic diagnosis.
The mechanism: why a vitamin produces a phantom sound
Tinnitus is not a disease of the ear alone. It is the perception of sound without an external source, and most cases involve some combination of cochlear damage and abnormal central gain. The brain, deprived of normal input, turns up its internal amplifier. B12 sits upstream of both processes.
The vitamin is a cofactor for two enzymes that matter here. Methionine synthase recycles homocysteine into methionine, which feeds the methylation reactions that produce myelin. Methylmalonyl-CoA mutase converts methylmalonyl-CoA to succinyl-CoA, and when B12 is scarce, methylmalonic acid accumulates and disrupts fatty acid synthesis in nerve membranes. The result is faulty myelin: thinner, patchier, and slower to repair. In plain terms: B12 is one of the raw materials for the insulation on your auditory wiring, and insulation failure makes the wire noisy.
Nerve conduction studies show the consequence. Demyelinated fibers conduct at 10 to 30 meters per second instead of the normal 50 to 70, and they fire spontaneously. A cochlear nerve that fires without a sound stimulus transmits a signal the brain interprets as tone. B12 deficiency also raises homocysteine, which damages vascular endothelium. The cochlea is one of the most blood-flow-sensitive organs in the body, so microvascular compromise adds a second, independent route to tinnitus.
How common is the overlap?
The prevalence numbers put this in context. Chronic tinnitus affects roughly 10 to 15 percent of adults, with about 1 to 2 percent reporting it as severely debilitating. B12 deficiency, by some measures, is comparably widespread: 6 to 20 percent of adults under 60 in Western populations, rising to 20 to 40 percent in older adults.
| Population | Estimated B12 deficiency | Estimated chronic tinnitus | Notes |
|---|---|---|---|
| Adults 20-59 | 6-20% | 10-12% | Highest overlap in metformin users |
| Adults 60+ | 20-40% | 15-25% | Both rise with age-driven absorption loss |
| Strict vegans | 50-80% untreated | ~12% | Deficiency near-universal without supplementation |
| Long-term metformin users | 10-30% | 15% | Dose and duration dependent |
| Post-gastric-surgery | 40-60% | Elevated | Intrinsic factor loss |
These are not the same people, and that matters for interpretation. A shared prevalence of 15 percent does not prove causation. The case for a causal link rests on mechanism plus the fact that correcting B12 improves symptoms in a meaningful subset, which the next sections address.
B12 deficiency tinnitus: the specific symptom pattern
Not every tinnitus points to B12. The deficiency signature has a few distinguishing features. It is often bilateral, high-pitched, and steady rather than pulsatile. It tends to arrive alongside other neurological complaints: numbness and tingling in the feet, unsteadiness in the dark, mild cognitive fog, a sore tongue. In one study of 60 patients with vitamin B12 deficiency, more than 40 percent reported tinnitus, and it improved in most who were treated.
That combination of auditory plus peripheral nerve symptoms is the useful clinical clue. If tinnitus arrives together with new numbness or balance problems, B12 is worth testing. If tinnitus is the only symptom in a healthy 30-year-old, the yield of testing is lower but not zero.
Who is actually at risk
Risk clusters around absorption rather than intake, which is why "I eat plenty of B12" does not settle the question. The list below covers the groups where testing is most defensible:
- Adults over 60, because stomach acid and intrinsic factor production decline with age and 20 to 40 percent have low or borderline levels
- Strict vegans and vegetarians who do not supplement, since plant foods contain essentially no bioavailable B12
- Anyone on metformin for more than four months, which reduces B12 absorption in up to 30 percent of users
- Long-term users of proton-pump inhibitors or H2 blockers, which raise the pH that B12 absorption depends on
- People with Crohn's disease, celiac disease, or prior gastric or ileal surgery, including bariatric procedures
- Users of nitrous oxide recreationally, which inactivates B12 and can trigger acute neurological symptoms
The metformin and acid-suppressor routes are worth emphasizing because neither is obvious to patients. A person can have a normal diet and a persistent deficiency simply because their medication interferes with uptake at the terminal ileum.
Reading the numbers: thresholds and test interpretation
The serum B12 cutoff most labs use is 200 pg/mL, with a borderline zone of 200 to 300 pg/mL. That threshold is too blunt for neurological symptoms. Nerve damage can appear at levels between 200 and 300 in some patients, and a single serum value can be falsely normal in early deficiency.
The reconciliation is straightforward: treat the 200 pg/mL laboratory cutoff as a screening line, not a diagnostic ceiling, and confirm any borderline or symptomatic case with methylmalonic acid and homocysteine. These two metabolites rise before serum B12 falls and are more sensitive to tissue-level deficiency. A methylmalonic acid above 0.37 micromol/L or homocysteine above 15 micromol/L supports the diagnosis even when serum B12 sits at 250 pg/mL. In plain terms: the serum test tells you what is in the blood, and the metabolite tests tell you what is happening in the tissue.
Correcting deficiency also has a timeline. Oral therapy with 1,000 to 2,000 micrograms daily repletes most mild cases within 8 to 12 weeks, but neurological symptoms recover more slowly because myelin repair takes time. This is why tinnitus often improves over months, not days.
Timeline of B12 deficiency and tinnitus resolution
| Stage | Typical timing | What happens |
|---|---|---|
| Depletion starts | Months to years before symptoms | Tissue stores fall; serum may still read normal |
| Metabolite rise | Early | MMA and homocysteine climb above 0.37 micromol/L and 15 micromol/L |
| Neurological symptoms | Usually after sustained deficiency | Tinnitus, numbness, balance changes appear |
| Treatment begins | Day 0 | High-dose oral or injected B12 restores blood levels within days |
| Early improvement | 2-4 weeks | Fatigue and cognitive fog often lift first |
| Neurological recovery | 3-12 months | Myelin repair; tinnitus improvement is gradual and variable |
| Plateau | After 12 months | Residual tinnitus may persist if cochlear damage is permanent |
The table makes the key point: tinnitus is one of the slower symptoms to resolve, and some people carry residual sound even after B12 normalizes. That does not mean the B12 was irrelevant. It means the nerve damage had advanced further than the vitamin deficit alone could explain.
Correcting a misconception: B12 is not a guaranteed cure
The most common error is assuming that because B12 deficiency can cause tinnitus, B12 will therefore cure it. It will not, in most people with tinnitus. The best evidence supports B12 as one contributor among several, and treatment helps most when deficiency is genuine and symptoms are recent.
Two corrections follow. First, a normal B12 level does not rule out tissue deficiency; the metabolite tests do. Second, a positive response to B12 does not prove B12 caused the tinnitus, because nerve recovery and natural fluctuation can mimic improvement. The honest position, consistent with established neurology, is that B12 is a modifiable factor worth correcting but not a standalone remedy. Excess B12 supplementation in someone who is not deficient has no demonstrated benefit for tinnitus and is not recommended.
What to actually do
Concrete steps, in order, for someone with tinnitus who suspects B12:
- Get tested before supplementing. Serum B12 plus methylmalonic acid and homocysteine give the clearest picture.
- Review medications. Metformin, proton-pump inhibitors, and H2 blockers all affect absorption, and a conversation with a prescriber is warranted.
- Treat confirmed deficiency properly. Oral 1,000 to 2,000 micrograms daily, or injections if absorption is impaired, per clinician guidance.
- Give it time. Recheck levels at 8 to 12 weeks and allow 3 to 12 months for neurological symptoms to improve.
- Address the other contributors. Hearing protection, blood pressure control, and sleep hygiene each affect tinnitus independently of B12.
- Seek audiology review if tinnitus is unilateral, pulsatile, or accompanied by hearing loss, because those patterns point to causes beyond nutrition.
Red-flag symptoms that warrant prompt medical attention rather than self-supplementation:
- Tinnitus in one ear only, especially with hearing loss
- Pulsatile tinnitus that matches your heartbeat
- Sudden hearing loss alongside new tinnitus
- Tinnitus with facial weakness, severe headache, or neurological deficit
- Rapidly progressive numbness, gait instability, or memory decline
- Tinnitus after head injury or with new vertigo
Limitations and the state of the evidence
The evidence base has real limits. Most studies linking B12 to tinnitus are observational, and the strongest interventional data come from small trials rather than large randomized ones. A 2016 study found improvement in tinnitus severity after B12 treatment in deficient patients, but sample sizes were modest and follow-up short. Some of the best-known work on B12 and tinnitus comes from a 2004 study by Shemesh and colleagues, which reported improvement in a majority of treated patients but was not placebo-controlled.
Mechanism is better established than clinical response. We know with confidence that B12 is required for myelin and that demyelination produces abnormal nerve firing. We know less about how often that specific pathway accounts for a given patient's tinnitus. Age, noise exposure, and vascular health all contribute, and isolating B12's share is difficult. The practical takeaway respects that uncertainty: test, treat genuine deficiency, and expect partial rather than complete relief. B12 is one lever, and a safe one, but tinnitus usually has more than one cause.